The information on this page was last updated on 25 March 2025.
The Company’s shares are only traded on the London Stock Exchange’s AIM market at present.
The number of shares in issue is 196,546,800 ordinary shares of 10p each. No ordinary shares are held as treasury shares and therefore the total number of voting rights in the Company is 196,546,800.
There are no restrictions on the transfer of securities.
As far as the Company is aware, the percentage of the Company’s issued share capital not in public hands (as defined by the AIM Rules for Companies) is 12.07%.
In so far as the Company has been notified, the Company’s significant (3% or larger) shareholders are as follows.
Name |
Number of shares |
% of total ISC |
| Stonehage Fleming Investment Management Ltd | 29,787,261 |
15.01% |
| Jefferies International | 16,882,996 | 8.59% |
| Trafalgar Capital Management* | 16,042,660 | 8.16% |
| David and Monique Newlands | 13,110,500 | 6.67% |
|
Canaccord Genuity Wealth Management |
9,870,346 |
5.02% |
|
Columbia Threadneedle Investments |
9,081,884 |
4.62% |
|
Premier Milton Group plc |
8,529,969 | 4.34% |
| John McMullan | 7,112,144 | 3.6% |
* Held via CFD
Directors’ shareholdings
Name |
Number of shares |
% of total ISC |
|
John McMullan, Medical Director |
7,112,144 | 3.6% |
| Professor Prasad Godbole, Interim Chief Executive Officer (non-board) | 3,568,895 |
1.8% |
|
Simon Stilwell, Chairman |
1,966,000 |
1.00% |
| Bob Forsyth, Non-Executive Director | 150,000 | 0.08% |
For all shareholder enquiries, please contact John Charlton, Group Company Secretary, at john.charlton@totallyplc.com